Jaxtaposition

Knocking Out Rare Disease

Neuromuscular diseases start by hampering mobility and go on to threaten vital processes like breathing and swallowing. Spinal muscular atrophy may strike infancy, Duchenne muscular dystrophy in early childhood or amyotrophic lateral sclerosis in middle age. There may be hundreds of other neuromuscular diseases, some exceedingly rare.

And Greg Cox, Ph.D., wants to knock them all out.

 

September JAXTAPOSITION ME

View a write-up on Knocking Out Rare Diseases on September 11!

KNOCKING OUT RARE DISEASE

Neuromuscular diseases start by hampering mobility and go on to threaten vital processes like breathing and swallowing. Spinal muscular atrophy may strike infancy, Duchenne muscular dystrophy in early childhood or amyotrophic lateral sclerosis in middle age. There may be hundreds of other neuromuscular diseases, some exceedingly rare.

And Greg Cox, Ph.D., wants to knock them all out.

The Jackson Laboratory associate professor is at the hub of a network of researchers, mouse model experts, clinicians and patient families, all dedicated to finding the genetic causes and potential treatments for neuromuscular diseases.  

Join us for a fireside chat with Greg to learn about how he is helping patients and families by studying the genetics of degenerative muscle diseases using mouse models.  

When & Where

Wednesday, September 11, 2019
5:30 PM Reception
6:15 PM Program

Portland Museum of Art
Seven Congress Square
Portland, ME 04101

Greg Cox, Ph.D.

Greg Cox

Dr. Cox received his Bachelor of Science Degree in Biology (1989) from Humboldt State University in California and then moved on to earn a Ph.D. in Human Genetics from the University of Michigan in 1994. He arrived at The Jackson Laboratory at the end of 1994 to do his Postdoctoral training with Dr. Wayne Frankel studying the genetics of epilepsy and neuromuscular disorders. He started his own lab as an Associate Staff Scientist in 1999 and is currently an Associate Professor at JAX. Dr. Cox’s research program is focused upon molecular pathways necessary for the normal function and survival of motor neurons and their skeletal muscle targets.